CD4 and neoplasm: DCs capture tumor antigens and present them within major histocompatibility class (MHC) molecules to the naïve CD4+ and CD8+ T lymphocytes, resulting in their activation, proliferation and differentiation in effector CD4+ T helper (Th)cells and CD8+ cytotoxic T lymphocytes (CTLs) [2].